Genesco grows sales modestly, remains unprofitable; Journeys strong, Schuh weak

Genesco Inc. (NYSE: GCO) - quick read

What's happening inside the company
Genesco grew top line modestly but remains unprofitable. Management is leaning into stores (Journeys), executing a store-optimization program, investing in capex and marketing, and using the revolver to fund working capital and buybacks. A large IRS refund ($58.3M) temporarily improved liquidity. U.K. (Schuh) and certain licensed businesses continue to pressure margins.

Key points & statistics (facts from the 10‑Q)
* Net sales - Q2 FY2026: $545,965; Q2 FY2025: $525,188; Six months FY2026: $1,019,938; Six months FY2025: $982,785.
* Gross margin - Q2 FY2026: $249,949 (45.8% of sales); Q2 FY2025: $245,639 (46.8%). Six months FY2026: $471,130 (46.2%); prior six months: $461,920 (47.0%).
* Operating loss - Q2 FY2026: $(14,440); Q2 FY2025: $(10,274). Six months FY2026: $(42,585); prior six months: $(42,402).
* Net loss - Q2 FY2026: $(18,471) or $(1.79) per share; Q2 FY2025: $(9,992) or $(0.91). Six months FY2026: $(39,698) or $(3.82); prior six months: $(34,339) or $(3.14).
* Pretax loss - Q2 FY2026: $(16,047); Q2 FY2025: $(11,705).
* Effective tax rate - Six months FY2026: 13.2% (impacted by OBBBA tax law changes); Q2 FY2026 tax rate shown as (15.0)% due to timing and prior-quarter reversals.
* Cash and cash equivalents - Aug 2, 2025: $40,989 (up from $34,007 at Feb 1, 2025).
* Inventories - Aug 2, 2025: $501,008 (Feb 1, 2025: $425,224).
* Total assets / liabilities / equity - Assets: $1,421,925; Liabilities: $915,553; Total equity: $506,372 (all in thousands).
* Long-term debt / revolver borrowings - Total long-term debt carrying amount: $70,952 (fair value $71,064). U.S. revolver $53.4M, Canada revolver $4.3M, Schuh/UK revolver £10.0M ($13.3M) as of Aug 2, 2025. Excess availability under Credit Facility: $268.6M.
* Cash flow - Net cash used in operating activities (six months): $(14,693); cash used in investing: $(33,580); net cash provided by financing: $54,886. Net increase in cash: $6,982 for the six months.
* Capital expenditures - Six months FY2026: $33,580; FY2026 guidance expected ~$55-$65M total capex.
* Share repurchases - First six months FY2026: 604,531 shares repurchased for $12.6M (avg $20.79); remaining repurchase authorization: $29.8M as of Aug 2, 2025.
* Store count and segments - Total stores at Aug 2, 2025: 1,253. Journeys Group stores: 984 (strong performance); Schuh Group: 120 (weak U.K. retail environment). Journeys represented the best segment performance (comparable sales +9% in Q2). Schuh comparable sales down 4% in Q2 (local currency).

Positive aspects (income statement & operations)
* Revenue growth: Net sales +4.0% YoY in Q2 and +3.8% for six months - demand is not collapsing.
* Journeys momentum: strong comps (+9% Q2), improved operating margin versus prior year (expense leverage).
* Gross margin dollars increased (higher absolute gross profit even if % slipped) - Q2 gross profit $249.9M.
* Liquidity action: received $58.3M IRS refund, cash up to $40.99M and large revolver availability ($268.6M).
* Management is returning capital via buybacks (604k shares in H1) and investing in stores (capex plan remains significant).

Negative aspects (income statement & risks)
* Continued losses: operating loss Q2 $(14.44M), net loss Q2 $(18.47M) and six‑month net loss $(39.70M).
* Margin pressure: gross margin % declined (46.8% → 45.8% Q2) due to Schuh promotions, tariffs and licensing exits (Genesco Brands).
* Rising inventories: inventories up to $501.0M (ties up cash and increases markdown risk).
* Cash from operations negative: $(14.7M) in six months - company still depends on financing/cash reserves seasonally.
* Increased leverage/use of revolvers: borrowing increased vs prior year; current portion of long-term debt $13.3M added in Q2.
* Segment weakness: Schuh (U.K.) and parts of Genesco Brands showing significant margin deterioration and promotional activity.
* Tax/timing noise: effective tax rate swings due to OBBBA changes and valuation allowance interactions - tax benefit volatility complicates profitability comparisons.

Implications / succinct takeaways
Genesco is executing a dual strategy: invest in growth (stores, Journeys) while cutting underperforming footprint. Top-line is growing modestly, but profitability remains negative, driven by margin pressure in Schuh and licensing exits plus higher inventory and operating costs. Liquidity is acceptable near-term (cash + sizable revolver availability and a one-time IRS refund), but operating cash flow remains a concern until seasonal strength and margin fixes show sustainable improvement. Investors should watch: comparable-store trends at Schuh and Johnston & Murphy, inventory digestion, margin recovery, and whether buybacks continue if losses persist.

Data sourced from Genesco Inc. Form 10‑Q for the quarter ended August 2, 2025 (figures in thousands except per‑share amounts and where noted).